YB2/0 Cell Lines

  • 1.00 Dollar US$
  • Published date: May 30, 2018
    • Shirley, New York, United States

Creative Biolabs provides rat myeloma cell lines including YB2/0 and its derivatives as hosts for the manufacturing of recombinant monoclonal antibodies. Initially, rat myeloma cell lines were used as a fusion partner to generate rat hybridomas and have been poplar for several years. https://www.gmp-creativebiolabs.com/yb2-0-cell-lines_69.htm

Result 0 votes
Bella Smith
0 votes

Useful information

  • Avoid scams by acting locally or paying with PayPal
  • Never pay with Western Union, Moneygram or other anonymous payment services
  • Don't buy or sell outside of your country. Don't accept cashier cheques from outside your country
  • This site is never involved in any transaction, and does not handle payments, shipping, guarantee transactions, provide escrow services, or offer "buyer protection" or "seller certification"

Related listings

  • SP2/0 Cell Lines

    SP2/0 Cell Lines

    Drug Development Shirley (New York) May 30, 2018 1.00 Dollar US$

    As a burgeoning biotech company in the GMP field, Creative Biolabs utilizes unparalleled techniques and platforms to provide stable cell line development services of various cells including SP2/0. In the very beginning of large-scale antibody express...

  • NS0 Cell Lines

    NS0 Cell Lines

    Drug Development Shirley (New York) May 30, 2018 1.00 Dollar US$

    Creative Biolabs provides full services of recombinant NS0 cells for recombinant proteins production. It has been a number of years that NS0 cells work as fusion partners for the generation of hybridoma cells to produce monoclonal antibodies. https:/...

  • BHK Cell Lines

    BHK Cell Lines

    Drug Development Shirley (New York) May 30, 2018 1.00 Dollar US$

    BHK (Baby hamster kidney) cells line is one of the most commonly used cell lines for the expression of biopharmaceuticals, and it is also among the top three cell types that have been most frequently used for transient expression. Based on the most a...